Elevated levels of YKL-40 were found in the circulation of patients with various solid tumors including glioma, breast cancer, colorectal cancer, ovarian cancer, metastatic renal and prostate cancer, and malignant melanoma. This evidence concerns the gene CHI3L1 and ovarian carcinoma.